Your browser doesn't support javascript.
loading
Engaging European society at the forefront of cancer research and care: How discussions at the 5th Gago Conference on European Science policy led to the Heidelberg Manifesto
Baumann, Michael; Celis, Julio; Ringborg, Ulrik; Heitor, Manuel; Berns, Anton; Albreht, Tit; Arabadjiev, Jeliazko; Boutros, Michael; Brandenburg, Mario; Canhao, Helena; Carneiro, Fatima; Chomienne, Christine; De Lorenzo, Francesco; Eggermont, Alexander M M; Font, Angel; Garralda, Elena; Goulart, Margarida; Henrique, Rui; Lawler, Mark; Maier-Hein, Lena; Meunier, Francoise; Oberst, Simon; Oliveira, Pedro; Papatriantafyllou, Maria; Schüz, Joachim; Solary, Eric; Valencia, Alfonso; Vargas, Rosalia; Weiderpass, Elisabete; Wilking, Nils.
Afiliação
  • Baumann M; German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Celis J; European Academy of Cancer Sciences, Stockholm, Sweden.
  • Ringborg U; European Academy of Cancer Sciences, Stockholm, Sweden.
  • Heitor M; Danish Cancer Society Research Center, Copenhagen, Denmark.
  • Berns A; European Academy of Cancer Sciences, Stockholm, Sweden.
  • Albreht T; Cancer Center Karolinska, Karolinska University Hospital, Stockholm, Sweden.
  • Arabadjiev J; European Academy of Cancer Sciences, Stockholm, Sweden.
  • Boutros M; Center for Innovation, Technology and Policy Research, IN+ @ IS Técnico, University of Lisbon, Portugal.
  • Brandenburg M; European Academy of Cancer Sciences, Stockholm, Sweden.
  • Canhao H; The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Carneiro F; National Institute of Public Health of Slovenia, Ljubljana, Slovenia.
  • Chomienne C; Faculty of Medicine, University of Ljubljana, Slovenia.
  • De Lorenzo F; Clinic of Medical Oncology, University Hospital Acibadem City Clinic Tokuda, Sofia, Bulgaria.
  • Eggermont AMM; Bulgarian Scientific Society of Immuno-oncology, and MoC Board, Sofia, Bulgaria.
  • Font A; European Academy of Cancer Sciences, Stockholm, Sweden.
  • Garralda E; Division Signaling and Functional Genomics, German Cancer Research Center (DKFZ) and Heidelberg University, Germany.
  • Goulart M; DKFZ-Hector Cancer Institute at the University Medical Center Mannheim, Germany.
  • Henrique R; Federal Ministry of Education and Research (BMBF), Berlin, Germany.
  • Lawler M; Comprehensive Health Research Center (CHRC), NOVA Medical School, Universidade Nova de Lisboa, Portugal.
  • Maier-Hein L; European Academy of Cancer Sciences, Stockholm, Sweden.
  • Meunier F; Instituto de Patologia e Imunologia Molecular da Universidade do Porto (Ipatimup), Portugal.
  • Oberst S; Instituto de Investigação e Inovação em Saúde (i3S), Faculdade de Medicina da Universidade do Porto (FMUP), Portugal.
  • Oliveira P; Centro Hospitalar Universitário de São João (CHUSJ), Porto, Portugal.
  • Papatriantafyllou M; Université de Paris, France.
  • Schüz J; European Academy of Cancer Sciences, Stockholm, Sweden.
  • Solary E; European Cancer Patient Coalition, Brussels, Belgium.
  • Valencia A; European Academy of Cancer Sciences, Stockholm, Sweden.
  • Vargas R; Department Cancer Medicine, CSO Princess Máxima Centre Pediatric Oncology, University Medical Center Utrecht, The Netherlands.
  • Weiderpass E; Board of the Comprehensive Cancer Center Munich, Technical University Munich, Germany.
  • Wilking N; Ludwig Maximiliaan University, Munich, Germany.
Mol Oncol ; 17(6): 925-945, 2023 06.
Article em En | MEDLINE | ID: mdl-36938773
European cancer research stakeholders met in October 2022 in Heidelberg, Germany, at the 5th Gago conference on European Cancer Policy, to discuss the current cancer research and cancer care policy landscape in Europe. Meeting participants highlighted gaps in the existing European programmes focusing on cancer research, including Europe's Beating Cancer Plan (EBCP), the Mission on Cancer (MoC), Understanding Cancer (UNCAN.eu), and the joint action CRANE, and put forward the next priorities, in the form of the Heidelberg Manifesto for cancer research. This meeting report presents all discussions that shed light on how infrastructures can be effectively shaped for translational, prevention, clinical and outcomes cancer research, with a focus on implementation and sustainability and while engaging patients and the public. In addition, we summarize recommendations on how to introduce frameworks for the digitalization of European cancer research. Finally, we discuss what structures, commitment, and resources are needed to establish a collaborative cancer research environment in Europe to achieve the scale required for innovation.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Tipo de estudo: Guideline / Prognostic_studies Limite: Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Tipo de estudo: Guideline / Prognostic_studies Limite: Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2023 Tipo de documento: Article